HADHB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.502400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.301200E-01
Normal-vs-Stage2
2.635200E-01
Normal-vs-Stage3
1.560760E-01
Normal-vs-Stage4
6.153200E-01
Stage1-vs-Stage2
4.117000E-01
Stage1-vs-Stage3
2.894200E-01
Stage1-vs-Stage4
9.683000E-01
Stage2-vs-Stage3
2.835400E-01
Stage2-vs-Stage4
4.556200E-01
Stage3-vs-Stage4
1.620610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.202200E-01
Normal-vs-AfricanAmerican
8.149000E-01
Normal-vs-Asian
1.982410E-01
Caucasian-vs-AfricanAmerican
2.799700E-02
Caucasian-vs-Asian
9.740600E-01
AfricanAmerican-vs-Asian
9.777500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.400800E-01
Normal-vs-Female
2.825800E-01
Male-vs-Female
7.586400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.771000E-01
Normal-vs-Age(41-60Yrs)
5.734000E-01
Normal-vs-Age(61-80Yrs)
1.342610E-01
Normal-vs-Age(81-100Yrs)
3.526200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.389200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.323200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.355400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.419200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.139200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.539400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.322400E-02
Normal-vs-Daily Drinker
2.208200E-01
Normal-vs-Weekly Drinker
6.421800E-02
Normal-vs-Occasional Drinker
2.508800E-01
Normal-vs-Social Drinker
4.159000E-01
Non Drinker-vs-Daily Drinker
5.771800E-01
Non Drinker-vs-Weekly Drinker
6.567800E-01
Non Drinker-vs-Occasional Drinker
1.251030E-01
Non Drinker-vs-Social Drinker
5.198400E-02
Daily Drinker-vs-Weekly Drinker
4.526800E-01
Daily Drinker-vs-Occasional Drinker
5.109800E-01
Daily Drinker-vs-Social Drinker
3.139800E-01
Weekly Drinker-vs-Occasional Drinker
1.311050E-01
Weekly Drinker-vs-Social Drinker
7.507600E-02
Occasional Drinker-vs-Social Drinker
6.454800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.021970E-01
Normal-vs-Grade 2
3.256200E-02
Normal-vs-Grade 3
6.782400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.407200E-01
Grade 1-vs-Grade 3
1.011620E-01
Grade 1-vs-Grade 4
1.021970E-01
Grade 2-vs-Grade 3
5.537800E-01
Grade 2-vs-Grade 4
3.256200E-02
Grade 3-vs-Grade 4
6.782400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.615810E-01
Normal-vs-NonDiabetic
1.257830E-01
Diabetic-vs-NonDiabetic
8.687800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.808600E-01
Normal-vs-NoPancreatitis
1.371560E-01
Pancreatitis-vs-NoPancreatitis
6.445000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.440400E-01
Normal-vs-N1
2.360400E-01
N0-vs-N1
9.133000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.286000E-02
Normal-vs-TP53-NonMutant
1.933230E-01
TP53-Mutant-vs-TP53-NonMutant
8.126000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
